FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q4 2019

SEC EDGAR SourceSEC Filings

Top Holdings116 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
AGNAGNDelisted

ALLERGAN PLC

8M$1.5B10.3%
3 qtrssince 2019-Q2
Increased
77
SPYSPY
PUT

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

4.4M$1.4B9.5%
Increased
WCGWCGDelisted

WELLCARE HEALTH PLANS INC

2.4M$792.5M5.3%
4 qtrssince 2019-Q1
Increased
62
2.1M$514.8M3.5%
2 qtrssince 2019-Q3
Increased
77

FIDELITY NATIONAL INFO SERV

3.5M$484.8M3.3%$99.04+24.01%
5 qtrssince 2018-Q4
Increased
65

WABTEC CORP

5.1M$394.4M2.7%$66.40+12.77%
5 qtrssince 2018-Q4
Decreased
0

ANTHEM INC

1.3M$377.5M2.5%$246.79+14.06%
5 qtrssince 2018-Q4
Increased
62

ALPHABET INC-CL C

274,903$367.6M2.5%$56.47+17.42%
5 qtrssince 2018-Q4
Increased
59
SMHSMH
PUT

VANECK SEMICONDUCTOR ETF

2.5M$354.2M2.4%
New

MICROSOFT CORP

2.2M$344.7M2.3%$116.20+28.77%
5 qtrssince 2018-Q4
Increased
75

CHARTER COMMUNICATIONS INC - CLASS A

683,093$331.4M2.2%$285.92+68.96%
5 qtrssince 2018-Q4
Decreased
0

THE CIGNA GROUP

1.5M$306.7M2.1%$175.20+5.97%
5 qtrssince 2018-Q4
Increased
71

IQVIA HOLDINGS INC

1.9M$286.6M1.9%$122.21+25.57%
5 qtrssince 2018-Q4
Decreased
0

VISA INC-CLASS A SHARES

1.5M$286.1M1.9%$135.72+31.91%
5 qtrssince 2018-Q4
Increased
57
MDCOMDCODelisted

MEDICINES CO

3.3M$281.6M1.9%
1 qtr
New
70

SALESFORCE.COM INC

1.7M$280.5M1.9%$160.490.00%
1 qtr
New
70

THERMO FISHER SCIENTIFIC INC

853,160$277.2M1.9%$320.030.00%
1 qtr
New
70
PLYAPLYADelisted

PLAYA HOTELS & RESORTS NV

30.6M$257.1M1.7%
5 qtrssince 2018-Q4
Unchanged
0

PALO ALTO NETWORKS INC

1.1M$256.3M1.7%$35.91+7.42%
2 qtrssince 2019-Q3
Increased
75
EQIXEQIX
REIT

EQUINIX INC

416,323$243M1.6%$331.96+56.36%
5 qtrssince 2018-Q4
Increased
54
$14.8B
AUM
116
Positions
Q4 2019
Filing
Rating · 1.5
Quarterly Portfolio Change
-3%Q1'19$13.3B+16%Q2'19$15.4B-14%Q3'19$13.2B+12%Q4'19$14.8B
Activity profile
$ moved · Q4'19
New25%Increased31%Decreased8%Exited36%
Composition
Equity vs derivatives
Equity88%Puts12%Calls0%
Holding period
Avg 2.7 quarters
<1Q27%1-4Q22%1-2Y47%2Y+5%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $14.8B across 116 positions as of Q4 2019. Top holdings: AGN (10.3%), SPY (9.5%), WCG (5.3%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1.5/5.0.

Q4 2019 Summary

Active quarter - 33 new positions, 18 exits, 39 increased. Top move: AGN (INCREASED, conviction 77). Portfolio: $14.8B across 116 positions.

Top holdings by portfolio weight

Total AUM$13B
AGN10.31%
WCG5.35%
HNIB3.47%
FIS3.27%
WAB2.66%
ELV2.55%
GOOG2.48%
MSFT2.33%
CHTR2.24%
CI2.07%
Other1.93%

Portfolio allocation by GICS sector

Sectors9
Unknown42.06%
Healthcare24.01%
Technology11.08%
Communication Services7.20%
Industrials5.25%
Financial Services4.68%
Real Estate2.12%
Consumer Cyclical1.90%
Basic Materials1.70%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown, Healthcare, Technology
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track Record60
Conviction43
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q3 2024 Q2 2026+8.5M shares+$314.1M
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 Q2 2026+9M shares+$755.7M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used